Category Archive for News Germany
News Germany – Health system, AMNOG, price negotiations, legal framework and how to navigate these successfully
German Emergency Care Reform Act proposed
Jens Spahn, Federal Minister of Health, has launched the Emergency Care Reform Act in hope of improving patients’ care when … read more »
The Dutch government removes Germany from its international reference pricing
The Rijksoverheid (Government of the Netherlands) has announced that Germany is no longer part of its international reference pricing basket. … read more »
GKV-FKG development: regulation to be enacted in spring 2020
The GKV-FKG – Gesetzliche Krankenversicherung Faire-Kassenwahl-Gesetz (Fair Health Insurance Law for the Statutory Health Insurance System) is expected to come … read more »
BPI Chief Executive: rebates lead to medicine shortages
The BPI – Bundesverband der Pharmazeutischen Industrie (The Federal Association of the Pharmaceutical Industry) has continued its criticism of the … read more »
G-BA and healthcare community call for tighter regulations of unlicensed high-cost medicines
The G-BA – The Gemeinsamer Bundesausschuss (Federal Joint Committee) and the wider healthcare community have called for stricter regulations of … read more »
BPI calls for more spending on Germany’s outpatient sector
Dr. Kai Joachimsen, the Chief Executive of BPI – Der Bundesverband der Pharmazeutischen Industrie (Federal Association of the Pharmaceutical Industry) … read more »
G-BA to publish decisions in English as well as German
The German Federal Joint Committee will publish its early benefit assessments in English as well as German, following adoption of … read more »
Doctors in Germany to be able to prescribe mobile health applications
The German Government has recently adopted a law that will allow the prescription of mobile health applications with statutory health … read more »
Provocative IQWiG publication in BMJ challenges pharmaceutical innovation model
An article published in the British Medical Journal by IQWiG has argued that over half of new drugs entering the … read more »
BPI argue GSAV passed without sufficient challenge
The Bundesrat did not use its opportunity to challenge aspects of GSAV legislation when it approved it earlier this year, … read more »
